Search

Search Constraints

You searched for: Author/Creator Galli, Luca

Search Results

1. 223Ra-chloride therapy in men with hormone-refractory prostate cancer and skeletal metastases: Real-world experience. Issue 2 (March 2018)

2. [18F]Choline PET/CT and stereotactic body radiotherapy on treatment decision making of oligometastatic prostate cancer patients: preliminary results. Issue 1 (December 2016)

4. An Italian, multicenter, real-world, retrospective study of first-line pazopanib in unselected metastatic renal-cell carcinoma patients: the 'Pamerit' study. (20th November 2020)

5. Androgen receptor (AR) splice variant 7 and full‐length AR expression is associated with clinical outcome: a translational study in patients with castrate‐resistant prostate cancer. (20th September 2019)

6. Characterization of 150 μm thick silicon microstrip prototype for the FOOT experiment. (1st December 2022)

7. Characterization of 150 μm thick silicon microstrip prototype for the FOOT experiment. (1st December 2022)

8. Concomitant Drugs Prognostic Score in Patients With Metastatic Renal Cell Carcinoma Receiving Ipilimumab and Nivolumab in the Compassionate Use Program in Italy: Brief Communication. Issue 1 (4th January 2023)

9. Docetaxel plus oral metronomic cyclophosphamide: A phase II study with pharmacodynamic and pharmacogenetic analyses in castration‐resistant prostate cancer patients. Issue 24 (8th August 2014)

10. Docetaxel rechallenge in metastatic castration-resistant prostate cancer: any place in the modern treatment scenario? An intention to treat evaluation. (November 2015)